Moderna Inc. (MRNA) |
|
70.75 0.23 (0.33%)
|
10-01 09:13 |
|
Open: |
72.51 |
Pre. Close: |
70.52 |
|
High:
|
75.39 |
Low:
|
70.16 |
|
Volume:
|
15,540,331 |
Market Cap:
|
27,917M |
|
|
|
|
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 760 full-time employees. The company has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. The company is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. The company has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. The company has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
71.428 - 71.693 |
71.693 - 71.906 |
|
Low:
|
68.875 - 69.209 |
69.209 - 69.477 |
|
Close:
|
69.533 - 70.044 |
70.044 - 70.455 |
|
Technical analysis |
as of: 2020-09-30 4:44:15 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 83.68 One year: 97.73 |
| Support: |
Support1: 60.87 Support2: 54.21 |
| Resistance: |
Resistance1: 71.64 Resistance2: 83.68 |
| Pivot: |
63.71  |
| Moving Average: |
MA(5): 68.70 MA(20): 64.64
MA(100): 66.18 MA(250): 40.23 |
| MACD: |
MACD(12,26): -0.32 Signal(9): -1.63 |
| Stochastic oscillator: |
%K(14,3): 89.38 %D(3): 85.16 |
| RSI: |
RSI(14): 56.62 |
| 52-week: |
High: 95.21 Low: 13.53 Change(%): 293.0 |
| Average Vol(K): |
3-Month: 2005736 10-Days: 997781 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.MRNA has closed below upper band by 16.2%. Bollinger Bands are 6.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 30 Sep 2020
Moderna Inc. stock rises Wednesday, still underperforms market - MarketWatch
Wed, 30 Sep 2020
Does Moderna Inc (MRNA) Have What it Takes to be in Your Portfolio? - InvestorsObserver
Wed, 30 Sep 2020
How Many Moderna, Inc. (NASDAQ:MRNA) Shares Have Insiders Sold, In The Last Year? - Simply Wall St
Tue, 29 Sep 2020
Moderna Inc. stock outperforms market despite losses on the day - MarketWatch
Mon, 28 Sep 2020
Moderna Inc. stock rises Monday, still underperforms market - MarketWatch
Mon, 28 Sep 2020
Moderna (MRNA) Back In Rally Mode - Investopedia
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
395 |
| Shares Float (M) |
324 |
|
% Held by Insiders
|
23.94 |
|
% Held by Institutions
|
53.53 |
|
Shares Short (K)
|
28,020 |
|
Shares Short P. Month (K)
|
27,190 |
Stock Financials |
|
EPS
|
-1.390 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
7.490 |
|
Profit Margin
|
|
|
Operating Margin
|
-485.03 |
|
Return on Assets (ttm)
|
-12.4 |
|
Return on Equity (ttm)
|
-22.8 |
|
Qtrly Rev. Growth
|
407.2 |
|
Gross Profit (p.s.)
|
-1.105 |
|
Sales Per Share
|
0.268 |
|
EBITDA (p.s.)
|
-1.222 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-336 |
|
Levered Free Cash Flow (M)
|
-304 |
Stock Valuations |
|
PE Ratio
|
-50.38 |
|
PEG Ratio
|
|
|
Price to Book value
|
9.35 |
|
Price to Sales
|
261.08 |
|
Price to Cash Flow
|
-82.20 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
